• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous X-ray and ultrasound solutions

    3/18/25 4:05:00 PM ET
    $GEHC
    Medical Electronics
    Health Care
    Get the next $GEHC alert in real time by email
    • Building on its 125-year legacy of medical imaging innovation and a 16-year relationship with NVIDIA, the two companies team up to advance AI-driven autonomous solutions designed to ease the growing burden on healthcare professionals.

    GE HealthCare (NASDAQ:GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound.

    GE HealthCare has been at the forefront of medical technology innovation with a series of "firsts" that date back more than a century, starting with the invention of its X-ray tube, followed by several others including the first handheld ultrasound, first 3D obstetric ultrasound, and on-device AI algorithms for pneumothorax triage. X-ray and ultrasound continue to be the most widely used diagnostic imaging systems with 4.2 billion medical imaging examinations performed annually at a global scale.i However, rising demand, driven by an aging population, has led to significant radiology staff shortages, challenging healthcare systems, increasing the burden on healthcare providers, and delaying critical diagnoses.ii

    Autonomous X-ray and ultrasound are promising new areas of development, using AI-enabled software to capture and analyze medical images, which could minimize the burden on technicians and radiologists. With NVIDIA as a world leader in accelerated computing and AI and GE HealthCare's position as a leading global healthcare solutions provider — topping the FDA list of AI-enabled device authorizations for three years in a row with 85 authorizationsiii — this collaboration plan has the potential to help solve some of healthcare's biggest challenges.

    GE HealthCare aims to develop AI-enabled X-ray and ultrasound systems by leveraging the new NVIDIA Isaac for Healthcare platform, built on NVIDIA's three computers utilized to build physical AI, including NVIDIA Omniverse for robotic simulation workflows. Using the NVIDIA Cosmos platform for synthetic data generation, physics-based sensor simulation, imitation, and reinforcement learning, GE HealthCare plans to train, test, and tune autonomous ultrasound and X-ray devices in a virtual environment before deployment in the physical world.

    "GE HealthCare has a deep history of firsts in medical imaging, and we continue to build upon our legacy of innovation as a healthcare solutions provider," said Roland Rott, president and CEO, Imaging at GE HealthCare. "We are excited about our expanded relationship with NVIDIA and the potential of autonomous X-ray and ultrasound as we are focused on unlocking smarter, more automated solutions that enhance efficiency, standardize imaging, and help ease the burden of increased volumes and double-digit staff shortages on healthcare professionals."

    Transforming X-ray workflow, efficiency and access

    NVIDIA and GE HealthCare will initially focus on autonomous development within X-ray systems, specifically the potential utilization of the NVIDIA Isaac for Healthcare and Jetson platforms. GE HealthCare plans to explore Isaac for Healthcare platform and synthetic data generation to simulate various scenarios. This will help to automate repetitive tasks performed by a technologist in the patient exam room. The goal is to enable care teams to focus more of their time on direct patient care and complex cases. The companies will also explore the development of machine-to-patient interactions to autonomously lead the patient through the scan journey.

    Advancing ultrasound solutions

    As ultrasound grows in popularity—and complexity—sonographers and radiology technologists face high patient volumes, long hours, and mental and physical stress. Approximately 90% of sonographers report work-related musculoskeletal disorders,iv and among U.S. health systems, 81% report radiology technologist shortages.v

    To help address these challenges, GE HealthCare and NVIDIA plan to explore the development of autonomous ultrasound systems to reduce the burden on sonographers and radiologists. For sonographers, autonomous ultrasound systems could streamline workflow and reduce demanding physical strain resulting from repetitive motions. In addition, AI has the potential to take on more of the daily workload though advancements in image understandingvi and robotic navigation.vii

    This work will build on a long-standing relationship between the two companies, spanning various areas of GE HealthCare's business. As an example of previous synergies, GE HealthCare used NVIDIA technology for the development of GE HealthCare's pioneering research foundation model SonoSAMTrackviii. SonoSAMTrack is a healthcare-specific research foundation model that GE HealthCare trained on approximately 200,000 image-mask pairs, which delineate diverse sets of regions of interest including organs and lesions, and exhibited an average similarity score of over 90%, indicating a high degree of segmentation accuracyix.

    "Artificial intelligence and physical AI offer an incredible opportunity to expand global access to GE HealthCare's advanced imaging systems," said Kimberly Powell, vice president of healthcare at NVIDIA. "Working together to train and test autonomous solutions, we will accelerate the future of medical imaging capabilities, starting with the two most widely used modalities: X-ray and ultrasound."

    Forward-Looking Statements

    This release contains forward-looking statements. These forward-looking statements might be identified by words, and variations of words, such as "will," "expect," "may," "would," "could," "plan," "believe," "anticipate," "intend," "aim," "estimate," "potential," "position," and similar expressions. These forward-looking statements may include, but are not limited to, statements about the collaboration, the anticipated outcomes of the collaboration, and any new products or solutions resulting from the collaboration or otherwise. These forward-looking statements involve risks and uncertainties, many of which are beyond the control of the Company. Factors that could cause the Company's actual results to differ materially from those described in its forward-looking statements include, but are not limited to, the Company's inability to achieve the anticipated benefits of the collaboration, business or commercial disruptions, and unexpected risks and liabilities impacting the Company. Other factors that may cause such a difference also include those discussed in the "Risk Factors" section of the Company's Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission and any updates or amendments it makes in future filings. There may be other factors not presently known to the Company or which it currently considers to be immaterial that could cause the Company's actual results to differ materially from those projected in any forward-looking statements the Company makes. The Company does not undertake any obligation to update or revise its forward-looking statements except as required by applicable law or regulation.

    About GE HealthCare Technologies Inc.

    GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.

    GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™.

    Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

    i Mahesh, Mahadevappa, Ansari, Armin J., and Fred A. Mettler, Jr. "Patient Exposure from Radiologic and Nuclear Medicine Procedures in the United States and Worldwide: 2009–2018." Radiology v. 307, no. 1 (2022). Accessed March 5, 2025. https://doi.org/10.1148/radiol.221263

    ii The American Society of Radiologic Technologists in 2022 and 2023 estimate that radiographer and sonographer vacancy rates in 2023 almost tripled from the rates in 2021, with 2023 vacancy rates reported at 18.1% for radiography and 16.7% for sonography. Source: American Society of Radiologic Technologists. Radiation Therapy Staffing and Workplace Survey 2022. Accessed March 5, 2025. https://www.asrt.org/docs/default-source/research/staffing-surveys/radiation-therapy-staffing-and-workplace-survey-2022.pdf; American Society of Radiologic Technologists. Radiologic Sciences Workplace and Staffing Survey 2023. Accessed March 5, 2025. https://www.asrt.org/docs/default-source/research/staffing-surveys/radiologic-sciences-workplace-and-staffing-survey-2023.pdf

    iii "Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices," December 20, 2024, https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices

    iv Work Related Musculoskeletal Disorders In Sonography, Society Of Diagnostic Medical Sonography, Susan Murphey, https://journals.sagepub.com/doi/full/10.1177/8756479317726767

    v "Radiology Staffing Shortages Nation Wide?", AHEC online, Sept 27, 2021.

    vi "Image-based Navigation in Real-World Environments via Multiple Mid-Level Representations." SpringerLink, 2023. Accessed March 5, 2025. https://link.springer.com/article/10.1007/s10514-023-10147-z

    vii Marasigan, John Albert L., and Yung-Hao Wong. "Adaptive Robotics: Integrating Robotic Simulation, AI, Image Analysis, and Cloud-Based Digital Twin Simulation for Dynamic Task Completion." Lecture Notes in Computer Science, 2024. Accessed March 5, 2025. https://link.springer.com/chapter/10.1007/978-3-031-60615-1_17

    viii This work is in concept phase and may never become a product. Not for sale. Not cleared or approved by the U.S. FDA or any other global regulator for commercial availability.

    ix Any reported results are preliminary and subject to change.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250318436532/en/

    GE HealthCare Media Contact:

    Karin Dalsin

    Global Communications Director

    M +1 612-219-2855

    [email protected]

    Get the next $GEHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GEHC

    DatePrice TargetRatingAnalyst
    1/15/2026$77.00Neutral → Sell
    UBS
    10/13/2025$86.00Equal Weight
    Barclays
    10/7/2025$83.00Buy → Neutral
    Citigroup
    5/5/2025$73.00Sell → Neutral
    UBS
    3/11/2025$85.00 → $100.00Neutral → Buy
    Goldman
    1/8/2025$95.00 → $103.00Hold → Buy
    Jefferies
    9/26/2024$84.00 → $74.00Neutral → Sell
    UBS
    9/18/2024$100.00Neutral → Buy
    BTIG Research
    More analyst ratings

    $GEHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lobo Kevin was granted 777 shares (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    3/17/26 4:08:18 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form 3 filed by new insider Lobo Kevin

    3 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    3/17/26 4:06:05 PM ET
    $GEHC
    Medical Electronics
    Health Care

    CEO, Patient Care Solutions Bankes Jeannette was granted 6,861 shares, increasing direct ownership by 19% to 43,892 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    3/4/26 4:27:18 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.

    SCHEDULE 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    3/26/26 6:37:20 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form DEFA14A filed by GE HealthCare Technologies Inc.

    DEFA14A - GE HealthCare Technologies Inc. (0001932393) (Filer)

    3/19/26 7:03:57 AM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form DEF 14A filed by GE HealthCare Technologies Inc.

    DEF 14A - GE HealthCare Technologies Inc. (0001932393) (Filer)

    3/19/26 7:02:54 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GE HealthCare downgraded by UBS with a new price target

    UBS downgraded GE HealthCare from Neutral to Sell and set a new price target of $77.00

    1/15/26 8:32:16 AM ET
    $GEHC
    Medical Electronics
    Health Care

    Barclays initiated coverage on GE HealthCare with a new price target

    Barclays initiated coverage of GE HealthCare with a rating of Equal Weight and set a new price target of $86.00

    10/13/25 8:53:16 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare downgraded by Citigroup with a new price target

    Citigroup downgraded GE HealthCare from Buy to Neutral and set a new price target of $83.00

    10/7/25 8:57:17 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GE HealthCare to announce first quarter 2026 results on April 29, 2026

    GE HealthCare (NASDAQ:GEHC) will announce its first quarter 2026 financial results before the market opens on Wednesday, April 29, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutic

    4/6/26 7:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare Recommends Shareholders Reject "Mini-Tender" Offer by Potemkin Limited

    GE HealthCare Technologies Inc. (NASDAQ:GEHC) (the "Company" or "GE HealthCare") announced today that it received notice on March 30, 2026, of an unsolicited "mini-tender" offer by Potemkin Limited to purchase up to 100,000 shares of GE HealthCare common stock at a price of $45.80 per share in cash. Potemkin Limited's offer price of $45.80 per share is approximately 34.80 percent lower than the $70.25 closing per share price of GE HealthCare's common stock on March 18, 2026, the last trading day before the mini-tender offer appears to have commenced. GE HealthCare does not endorse Potemkin Limited's unsolicited mini-tender offer and recommends that stockholders do not tender their shares

    3/31/26 4:10:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    How Decentralized AI is Unlocking Value in Cardiac Diagnostics

    ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.VANCOUVER,BC, March 27, 2026 /CNW/ -- USANewsGroup.com News Commentary – Heart disease is a quiet crisis that is draining healthcare resources worldwide, currently costing the European Union over €282 billion annually while tragically claiming 1.7 million lives a year[1]. This immense structural pressure is acting as a catalyst for smart money, with institutional capital rapidly accumulating positions in scalable, AI-enabled diagnostic platforms. In fact, peer-reviewed data now confirms that AI-driven healthcare startups command the largest share of venture funding in the entire biopharmaceutical sector[2]. At the center of this pivotal transit

    3/27/26 9:30:00 AM ET
    $BEAT
    $GEHC
    $HTFL
    Medical/Dental Instruments
    Health Care
    Medical Electronics
    Biotechnology: Electromedical & Electrotherapeutic Apparatus

    $GEHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Jimenez Frank R bought $100,624 worth of shares (1,315 units at $76.52), increasing direct ownership by 2% to 75,796 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    5/2/24 6:00:38 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Leadership Updates

    Live Leadership Updates

    View All

    GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors

    GE HealthCare (NASDAQ:GEHC) announced today the appointment of Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE:SYK), to its Board of Directors effective March 13. Mr. Lobo brings more than 25 years of medical technology, operational, and financial leadership experience. His clinical expertise and track record of driving innovation and scaling global businesses make him well qualified to contribute to GE HealthCare's strategic priorities. "Kevin is a seasoned healthcare executive with a deep understanding of the medical technology landscape. His knowledge and insight will further strengthen our Board as we continue to build a more personalized, connected and s

    3/17/26 9:00:00 AM ET
    $GEHC
    $SYK
    Medical Electronics
    Health Care
    Medical/Dental Instruments

    PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer

    BOCA RATON, Fla., June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp. ("PharmaLogic" or "the Company"), a leading contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, today announces the Company has appointed Etienne Montagut, currently serving as President, to the position of President and Chief Executive Officer, effective as of 1 June 2025. Mr. Montagut brings over 25 years of senior leadership experience in the pharmaceutical sector, with a solid track record of driving growth and executing strategic transformation across glob

    6/2/25 8:00:00 AM ET
    $GEHC
    $LNTH
    Medical Electronics
    Health Care
    Biotechnology: In Vitro & In Vivo Diagnostic Substances

    GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions

    GE HealthCare (NASDAQ:GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effective May 1, 2025. Peter Arduini, president and CEO, GE HealthCare, said, "Jeannette is a proven leader who has diverse and deep experience at publicly traded companies in the healthcare industry. We proudly welcome her to the company and are confident that she has the expertise to move Patient Care Solutions forward and deliver on our precision care strategy." Bankes brings with her three decades of global experience including product management, marketing, sales, regulatory, medical affairs, and operations and manufa

    4/9/25 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Financials

    Live finance-specific insights

    View All

    GE HealthCare to announce first quarter 2026 results on April 29, 2026

    GE HealthCare (NASDAQ:GEHC) will announce its first quarter 2026 financial results before the market opens on Wednesday, April 29, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutic

    4/6/26 7:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare completes Intelerad acquisition – accelerating shift to cloud-first enterprise solutions to deliver precision care

    Expands GE HealthCare's enterprise imaging footprint by delivering comprehensive, end‑to‑end solutions across ambulatory, teleradiology, and hospital care settings Advances GE HealthCare's D3 strategy by accelerating the development of disease‑focused smart devices and solutions enabled by digital (cloud and software) and artificial intelligence (AI) capabilities Enhances a fully connected, cloud‑first imaging ecosystem with an expanded GE HealthCare portfolio of AI, digital tools, and SaaS offerings designed to improve clinical operations Tuck‑in acquisition expected to strengthen the Imaging portfolio, increase recurring revenue mix, and support sustainable top‑line growth and p

    3/18/26 4:00:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare announces cash dividend for first quarter of 2026

    The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world's most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patie

    2/12/26 6:11:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    11/12/24 12:53:28 PM ET
    $GEHC
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    10/22/24 4:16:16 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form SC 13G/A filed by GE HealthCare Technologies Inc. (Amendment)

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    4/2/24 4:07:29 PM ET
    $GEHC
    Medical Electronics
    Health Care